503A and 503B compounding pharmacy, Houston, TX · Not an Ozari pharmacy · Checked November 14, 2026
Empower Pharmacy is a 503A and 503B compounding pharmacy based in Houston, TX. Its main phone number is (877) 562-8577. Since 2023, FDA's public records list three warning letters and four Form 483s for Empower Pharmacy and its related facilities. The most recent is a warning letter dated September 18, 2026. Lavender Sky Health and Ivím Health list it on their own websites. Empower Pharmacy does not fill Ozari prescriptions.
| Type | 503A and 503B |
|---|---|
| Legal name | Empower Clinic Services, LLC dba Empower Pharmacy; Empower Pharma (503B) |
| Based in | Houston, TX |
| Phone | (877) 562-8577 |
| Hours | Call center Monday to Friday, 7:00 AM to 7:00 PM |
| Website | empowerpharmacy.com |
| FDA 503B registration | Empower Pharma, Houston, TX: registered 7/16/2016, most recent registration 10/13/2026. Empower Clinic Services New Jersey, East Windsor, NJ: registered 6/10/2024, not yet inspected. |
| FDA actions listed | 8, most recent September 18, 2026 |
| Telehealth brands that name it | Lavender Sky Health and Ivím Health |
| Fills Ozari prescriptions | No |
Empower describes its 503A pharmacy as PCAB-accredited and offers compounded semaglutide with cyanocobalamin and tirzepatide with niacinamide to prescribers. Source.
503A pharmacy
7601 N Sam Houston Pkwy W, Ste 100, Houston, TX 77064
(877) 562-8577
Second Houston location
5980 W Sam Houston Pkwy N, Ste 300, Houston, TX 77041
(877) 562-8577
Questions about an order or a login go to Empower Pharmacy or the telehealth company that sent the prescription. Ozari cannot see or change Empower Pharmacy orders.
Since 2023, FDA's public records list three warning letters and four Form 483s for Empower Pharmacy and its related facilities. The most recent is a warning letter dated September 18, 2026.
| Date | FDA action | Facility named |
|---|---|---|
| September 18, 2026 | Warning letter FDA wrote that tirzepatide/niacinamide and semaglutide/cyanocobalamin products the firm compounded appear to be essentially copies of FDA-approved semaglutide and tirzepatide products. | Empower Clinic Services, LLC dba Empower Pharmacy (503A), Houston |
| June 3, 2026 | Response letter (after the 11/14/2025 inspection) | Empower Pharma (503B), Houston |
| November 14, 2025 | Form 483 | Empower (503A and 503B), Houston |
| April 2, 2025 | Warning letter | Empower Clinic Services, LLC dba Empower Pharmacy (503A), Houston |
| April 2, 2025 | Warning letter | Empower Clinic Services, LLC dba Empower Pharma (503B), Houston |
| October 4, 2024 | Form 483 | Empower Pharmacy (503A), Houston |
| August 28, 2024 | Form 483 | Empower (503B), Houston |
| December 1, 2023 | Form 483 | Empower Pharmacy (503A), Houston |
A Form 483 lists conditions an FDA investigator observed during an inspection. It is not a final agency finding, and the pharmacy can respond. A warning letter is FDA's formal notice that it found significant violations. Records come from FDA's compounding inspections and actions list and registered outsourcing facility list, checked November 14, 2026.
These brands name Empower Pharmacy on their own websites:
Many brands do not publish which pharmacy fills their orders. If yours does not say, ask before you pay, and check the name printed on your vial label.
Ozari names every pharmacy that fills its prescriptions and publishes each one's type, address, credentials and contact details, so you can run the checks above before you start.
FDA does not approve pharmacies. A 503A pharmacy is licensed by state boards of pharmacy, and a 503B outsourcing facility registers with FDA and is inspected against federal manufacturing standards. The compounded medications Empower Pharmacy prepares are not FDA-approved.
Empower runs a 503A compounding pharmacy in Houston and two FDA-registered 503B outsourcing facilities, Empower Pharma in Houston and Empower Clinic Services New Jersey in East Windsor.
Empower Pharmacy is at 7601 N Sam Houston Pkwy W, Ste 100, Houston, TX 77064. Its main phone number is (877) 562-8577. Posted hours: Call center Monday to Friday, 7:00 AM to 7:00 PM.
Since 2023, FDA's public records list three warning letters and four Form 483s for Empower Pharmacy and its related facilities. The most recent is a warning letter dated September 18, 2026. A Form 483 lists conditions an FDA investigator observed during an inspection and is not a final agency finding. A warning letter is FDA's formal notice of significant violations.
Lavender Sky Health and Ivím Health list Empower Pharmacy on their own websites. Other brands may use it without saying so.
No. Empower Pharmacy does not fill Ozari prescriptions. Ozari names the pharmacies that do, with their type, address and credentials, on its Pharmacy Standards page.
Compounded semaglutide and tirzepatide are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Empower Pharmacy is not affiliated with Ozari Health, and this page is not a review of its products or services. Facts on this page come from Empower Pharmacy's own website, FDA's public records and telehealth brands' own websites, checked November 14, 2026. See something out of date? Email press@ozarihealth.com. Other pharmacies in the directory.
Join thousands of patients who have already transformed their lives with science-backed weight loss treatment.
Get Started — It's Free